To compare the differences of hospital stays, hospitalization costs and effectiveness via keyhole hematoma debridement(KHED)and internal medicine conservative treatment(IMCT)in treating 30-40 mL hypertensive intracerebral hemorrhage.

Fifty-eight patients with hypertensive intracerebral hemorrhage whose bleeding was 30-40 mL, admitted to our hospital from January 2014 to September 2015, were chosen in our study; according to the will of the patients and their family members, the patients were divided into KHED group(n=31)and IMCT group(n=27). The differences of hospital stays, hospitalization costs, neurological dysfunction rate at hospital and three months after discharge, and recovery results were compared between the two groups.

The average hospital stays of KHED group were(7.4±2.3)d and those of IMCT group were(14.5±5.1)d, with significant difference(P=0.012); the hospitalization costs for the two groups were(36 296.28± 5292.12)yuan, and(41 769.48±6342.83)yuan, with significant difference(P=0.027). Glasgow outcome scale of KHED group at discharge indicated 29 patients with good recovery and 2 with poor recovery; that of IMCT group indicated 20 with good recovery and 7 with poor recovery, including two with cerebral edema accepted craniotomy operation in second time. Follow-up for three months showed that the KHED group had basic activities of daily living in 16 patients, mild hemiplegia in 11 and severe hemiplegia in 4, and IMCT group had basic activities of daily living in 9 patietns, mild hemiplegia in 13 and severe hemiplegia in 5; significant differences were noted between the two groups(Z=2.499, P= 0.001).

KHED in treatment of 30-40 mL hypertensive intracerebral hemorrhage can shorten hospitalization time, reduce cost, have better prognosis and better short-term and long-term effectiveness than IMCT.

Hypertensive intracerebral hemorrhage; Keyhole hematoma evacuation; Conservative treatment